1-2 of 2
Keywords: Biomarkers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Co-Expression of HSV2 and Chlamydia trachomatis in HPV-Positive Cervical Cancer and Cervical Intraepithelial Neoplasia Lesions Is Associated with Aberrations in Key Intracellular Pathways

Subject Area:
Further Areas
Pierpaolo Paba, Daniela Bonifacio, Luigi Di Bonito, Domenico Ombres, Cartesio Favalli, Kari Syrjänen, Marco Ciotti
Journal: Intervirology
Intervirology (2008) 51 (4): 230–234.
https://doi.org/10.1159/000156481
Published Online: 24 September 2008
... genotyped by InnoLipa. Monitoring of aberrations in key intracellular pathways due to CT/HSV2 and HPV co-expression were analyzed with 13 biomarkers. Results: Of the 149 samples tested, 136 were HPV DNA positive; 32/136 contained also CT DNA and 29 HSV2 DNA. Detection of CT was significantly (p = 0.0001...
View article titled, Co-Expression of HSV2 and Chlamydia trachomatis in HPV-Positive Cervical Cancer and Cervical Intraepithelial Neoplasia Lesions Is Associated with Aberrations in Key Intracellular Pathways
Open the PDF for Co-Expression of HSV2 and Chlamydia trachomatis in HPV-Positive Cervical Cancer and Cervical Intraepithelial Neoplasia Lesions Is Associated with Aberrations in Key Intracellular Pathways in another window
Journal Articles

A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score

Subject Area:
Further Areas
Satoshi Kitai, Masatoshi Kudo, Yasunori Minami, Kazuomi Ueshima, Hobyung Chung, Satoru Hagiwara, Tatsuo Inoue, Emi Ishikawa, Shunsuke Takahashi, Yutaka Asakuma, Seiji Haji, Yukio Osaki, Hiroko Oka, Toshihito Seki, Hiroshi Kasugai, Yo Sasaki, Takashi Matsunaga
Journal: Intervirology
Intervirology (2008) 51 (Suppl. 1): 86–94.
https://doi.org/10.1159/000122599
Published Online: 10 June 2008
... Staging (JIS) score has been reported to have good stratification ability in patients with hepatocellular carcinoma (HCC). However, the JIS score could not estimate malignant grade of HCC. The aim of this study was to evaluate the performance of a new staging system: the biomarker combined JIS (bm-JIS...
View article titled, A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the <span class="search-highlight">Biomarker</span> Combined Japan Integrated Staging Score
Open the PDF for A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the <span class="search-highlight">Biomarker</span> Combined Japan Integrated Staging Score in another window